FMBA has registered a rapid test to detect COVID strains :: Society :: RBC

FMBA has registered a rapid test to detect COVID strains :: Society :: RBC

Share Button

FMBA has registered a rapid test to detect COVID strains :: Society :: RBC

A new test system developed by the Federal Medical and Biological Agency (FMBA) of Russia to detect strains of coronavirus from “alpha” to “delta” has received a registration certificate. This is stated on the agency’s website.

The test system “AmpliTest SARS-CoV-2 VOC v.2” was developed by the Center for Strategic Planning and Management of Medical and Biological Health Risks of the FMBA on behalf of the head of the agency Veronika Skvortsova. It is capable of detecting strains of the coronavirus such as alpha (British), beta (African), gamma (Brazilian) and delta (Indian).

What tests for antibodies against COVID-19 are needed and why. Instructions

“The system allows you to identify the most significant genetic lines of the new coronavirus infection in just two hours, which is currently very important for use in epidemiological practice to understand the characteristics of the pathogen and to predict the clinical picture of the disease,” said Skvortsova.

In February, Russia registered two tests at once to identify strains of coronavirus. The first test was developed by the Central Research Institute of Epidemiology of Rospotrebnadzor.

Share Button
News